A practical approach to evaluating and treating neutropenia in the neonatal intensive care unit.
Neutropenia is a relatively common problem in the NICU, recognized in as many as 8% of patients at some time during their hospital stay. In most instances, neutropenia among NICU patients is of short duration and has little influence on outcome. In other cases it is prolonged and severe, and constitutes a serious antimicrobial defense deficiency. When a neonatologist discovers a low blood neutrophil count, choices must be made regarding further evaluation and treatment. The authors hope that the information provided in this article is useful in making these choices.
Christensen
R D
RD
Department of Pediatrics, University of Florida College of Medicine, Gainesville, USA. Chrisrd@peds.ufl.edu
Calhoun
D A
DA
Rimsza
L M
LM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D009503:Neutropenia / Q000175:diagnosis* / Q000628:therapy*; D009504:Neutrophils / Q000637:transplantation; D011994:Recombinant Proteins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D016756:Immunoglobulins, Intravenous; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor